In soft tissue sarcoma, YAP inhibits the expression of ubiquitin specific peptidase 31 (USP31), a key upstream negative regulator of NF-κB, thereby diminishing its inhibitory effect on NF-κB activity (Ye et al., 2018). This evidence concerns the gene NFKB1 and soft tissue sarcoma.